for Mar 22, 2019 through Mar 28, 2019
NEW🔥 in OFID @stoverkr/ @klusardi41/ @BBookstaver_USC and @blandman19
— Antibiotic Steward (@ABsteward) March 26, 2019
Baker’s Dozen of Top Antimicrobial Stewardship Intervention Publications in 2017. https://t.co/q8Rho7u6DL pic.twitter.com/r1BTXQRm7a
NEW 🔥 in @ICHEJournal @KimberlyBlumen1 @ericashenoy @dberkpharmd
— Antibiotic Steward (@ABsteward) March 27, 2019
An antimicrobial stewardship intervention consisting of β-lactam test-dose challenge procedure was safe. Overall, 3.8% of patients with β-lactam allergy histories had an HSR. #IDTwitter https://t.co/IXn6rvaOlV pic.twitter.com/sfmRbq64dn
NEW 🔥🔥 Systematic review and meta-analysis in #CMI @ASPphysician @Guru_JoshD Cefazolin Vs. anti-staphylococcal penicillins for the treatment of patients with MSSA bacteremia.
— Antibiotic Steward (@ABsteward) March 28, 2019
Read full article 👇#IDTwitter #IDMedEd #CLOCEBA https://t.co/EXldHDn5CA pic.twitter.com/oDYO3E0FIH
💊💊💊 ➡️ 🛡🦠🛡
— Bug Pharmacist (@IDstewardship) March 28, 2019
In case you need more reason to try to reduce #antibiotic exposure in ICUs.
👉 https://t.co/Ip4bPjk05n via @ACCP @JACCPJournal @PharmacoJournal #AntibioticTimeout #SaveABX #IDtwitter pic.twitter.com/28cM1cSGtG
A NEW🔥 RCT 🇻🇳 @BNadjm MALDITOF-MS, in the absence of an ASP, did NOT improve the proportion on optimal antimicrobial therapy at 24 or 48 hours after 1st growth in a LMIC setting with high rates of antibiotic resistance.
— Antibiotic Steward (@ABsteward) March 24, 2019
RDT + ASP is better. Cc @manfordou https://t.co/Vk6HMWpd9R pic.twitter.com/0FjRm5RJ4y
Tackling antimicrobial resistance is not just about new drugs, it's also about new approaches. Antibiotic stewardship, vaccines and diagnostics are key areas needing more research. Here's how the NIHR is supporting research on #AMR https://t.co/mhQ7fuCl7o #TacklingAMR #EconAMR pic.twitter.com/d3DC4NXooW
— NIHR CRN (@NIHRCRN) March 26, 2019
NEW 🔥 in @AJICJournal : LESS IS MORE : Antipseudomonal combination therapy has a higher mortality rate than monotherapy in adults with community-onset pneumonia. Read full article. #IDTwitter https://t.co/UDXyrAf0Vh pic.twitter.com/2ADjQENJma
— Antibiotic Steward (@ABsteward) March 22, 2019
60 to 70% of average penicillin “allergic” individuals can be safely delabeled with a direct oral amoxicillin challenge. @WalterReedArmy @KPSanDiego
— Eric Macy (@EricMacyMD) March 26, 2019
Evaluating Penicillin Allergies Without Skin Testing. - PubMed - NCBI https://t.co/05KJpoDezr
NEW🔥 In #CMI
— Antibiotic Steward (@ABsteward) March 23, 2019
Applying EUCAST instead of CLSI breakpoints to E. coli, K. pneumoniae & P. aeruginosa isolates would have increased rates of ciprofloxacin resistance (59.1% vs 46.5% in E. coli, 37.5% vs 13.9% in KP, 28.2% vs 10.3% in PSA. #IDTwitter https://t.co/Ghi4qOkA4z pic.twitter.com/yz4ni2lrIV
Eek! So thrilled that my @sciam feature "American Epidemic," on how economics and infrastructure drive the spread of infectious diseases in the U.S., has won a 2nd place award in the @AHCJ Awards for Excellence in Health Care Journalism! https://t.co/iT5923UOwf
— Melinda Wenner Moyer (@lindy2350) March 27, 2019
Globe editorial: Why humans ignore the slow-motion catastrophes all around them. Relevant to #AntimicrobialResistance https://t.co/YB77p92fYj
— Andrew Morris (@ASPphysician) March 28, 2019
Twitter to engage, educate, and advocate for global antibiotic stewardship and antimicrobial resistance https://t.co/qsucaPF8we
— SIDP (@SIDPharm) March 23, 2019
NEW RCT 🔥🔥@InfectDis_Ther @ClaeysKcclaeys @jpogue1@IDPharmProf @IDpharmresearch @Keith_S_Kaye
— Antibiotic Steward (@ABsteward) March 27, 2019
Open-Label Randomized Trial of Early Clinical Outcomes of Ceftaroline Fosamil Vs Vancomycin for the Treatment of ABSSSIs at Risk of MRSA https://t.co/rTE9zxMt5w pic.twitter.com/C04nWaDwzy
On #WorldTBDay check out #tuberculosis content in March issue https://t.co/XeljAzBdUB; a bumper crop of comments, research article, series of 3 papers, & a review #LancetTB pic.twitter.com/xdmFCNKyuw
— The Lancet Infectious Diseases (@TheLancetInfDis) March 24, 2019
NEW🔥 study in @JACCPJournal evaluated the impact of providing peer comparison reports to high volume FQ prescribers on FQ utilization across a 16-facility community hospital system
— Antibiotic Steward (@ABsteward) March 24, 2019
FQ use ⬇️ by 29%
HA-CD ⬇️ by 20% cc @manfordou#idtwitter #IDMedEd https://t.co/T0ZHfvGUV9 pic.twitter.com/fcFPHq7PYc
Interested in how to reduce antibiotic resistance? Keep your eye on these 5 key areas in 2019: https://t.co/RqEKoebCql
— Save Antibiotics (@saveantibiotics) March 25, 2019
On BacterioFiles: Newly discovered giant virus from a hot spring turns its amoeba hosts to stone! https://t.co/nlij9bv7zo image: Medusa, by Caravaggio (1595) pic.twitter.com/MwlGw2bANz
— ASM (@ASMicrobiology) March 24, 2019
Prescribers working in hospitals with long-standing ASPs worry less about their autonomy being threatened and more about their efficiency being disrupted. @julieszymczak @DrEimearKitt
— ICHE Journal (@ICHEJournal) March 28, 2019
Full article: https://t.co/FjrNaWqoRE pic.twitter.com/irxAIiwRBW
6 /10 of threats to global health in 2019 by @WHO are related to the Infectious Diseases! #IDTwitter #IDMedEd #AntibioticResistance
— Antibiotic Steward (@ABsteward) March 22, 2019
Global influenza pandemic
Antimicrobial resistance
Ebola & other high-threat pathogens
Vaccine hesitancy
Dengue
HIVhttps://t.co/wDHBuulB6J
The risk of anaphylaxis with parenteral cephalosporins is only about 1 in 80000, less than 1 in 200000 with oral exposures, and not elevated in individuals with unconfirmed penicillin “allergy”.https://t.co/2cfAxBN3XV https://t.co/tMGJr0tCqw
— Eric Macy (@EricMacyMD) March 28, 2019
New online: Effect of Plasmodium falciparum sulfadoxine-pyrimethamine resistance on the effectiveness of intermittent preventive therapy for #malaria in pregnancy in Africa: a systematic review and meta-analysis #OpenAccess https://t.co/pmkBtOyO8X
— The Lancet Infectious Diseases (@TheLancetInfDis) March 26, 2019
Our publishing of this article represents the culmination of a few years of hard work implementing this important #antimicrobial stewardship intervention across Partners Healthcare. Truly inspiring impact @KimberlyBlumen1 https://t.co/jb58R4CVi6 @newtonwellesley @PartnersNews pic.twitter.com/F6LXwOwxnd
— David Berkowitz (@dberkpharmd) March 27, 2019
The drugs don’t work: what happens after antibiotics?
— AMR at Wellcome (@Wellcome_AMR) March 25, 2019
Great piece in the @ObserverUK yesterday featuring our head of programme Tim Jinks and @CARB_X
Read more ➡️ https://t.co/9tk5bS6YtE
The Costs of Drugs in Infectious Diseases: Branded, Generics, and Why We Should Care. - Great article by @RWalensky reminding us that as healthcare providers we can no longer afford to ignore costs of healthcare including drug price. @HIVMA https://t.co/l6Qp3wGhTy
— Carlos del Rio (@CarlosdelRio7) March 24, 2019
Great read on recent "ACTIONABLE" antimicrobial stewardship interventions, including nasal MRSA PCR, rapid diagnostics, antibiotic allergy assessments...& much more! #antibioticstewardship Top Antimicrobial Stewardship Intervention Publications in 2017 https://t.co/ygVzVpNfN5
— Duke Raleigh ABX Stewardship (@AbxDukeRaleigh) March 27, 2019
The #MMR vaccine is a safe, free vaccine that helps protect your child against #measles, mumps and rubella. These are all highly infectious diseases that can cause serious medical complications. Find out more here: https://t.co/eA4XScTqat @NHSinform #VaccinesWork https://t.co/sRyCtxL0XM
— Immunise Scotland (@NHSImmuniseScot) March 28, 2019
Sharing this one (new in CID) mainly for the title: 'Early Bird Gets the Flu: What Should Be Done About Waning Intraseasonal Immunity Against Seasonal Influenza?' https://t.co/3WC8cVmZS7
— Jon Otter (@jonotter) March 25, 2019
As New York state declares a #measles outbreak emergency, our latest Editorial takes a deep dive into #vaccine hesitancy and lack of trust both in the USA and globally https://t.co/CJKTCB1wT3 pic.twitter.com/SEXqavKSlR
— The Lancet Infectious Diseases (@TheLancetInfDis) March 28, 2019
Thanks for highlighting this pub! New annual series on intervention papers from @SERGE_45_ABX research team. Note, our 2016 version available in pre prints: https://t.co/LmXqkGTki8 #AntimicrobialStewardship https://t.co/ICi51tlWKD
— SE Research Group (@SERGE_45_ABX) March 26, 2019
🔥New Guidelines 🔥
— Ilan Schwartz MD PhD 🔬🍄🤒 (@GermHunterMD) March 23, 2019
Invasive #Aspergillosis in Solid Organ #Transplant Recipients: #Guidelines from the American Society of Transplantation (@AST_info) Infectious Diseases Community of Practice
By Shahid Husain (@shahidh80523771) & Jose Camargo https://t.co/nnP0ylKle8 pic.twitter.com/2rhgXCCeok
Woah! New guidelines! A must read! Cryptococcosis in Solid Organ Transplantation‐ Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice - Baddley - - Clinical Transplantation - Wiley Online Library https://t.co/D7dPN5SLgA
— Mahdee Sobhanie, MD (@IDRenaissanceMD) March 23, 2019
'"I thought I was going to die": why patients are no longer pooh-poohing faecal transplants: Bonnie is one of thousands finding freedom from Clostridium difficile bacteria through faecal microbiota transplantation' https://t.co/a4an9deZME
— Antibiotic Action (@TheUrgentNeed) March 25, 2019
Clinical Practice Guideline for the Management of Asymptomatic Bacteriuria: 2019 Update by the Infectious Diseases Society of America a https://t.co/XneaoXJ50R. Congrats to Kal, @bwtrautner. Now to get people to follow @tony_breu, @bostonchiefs, @kmfitani1.
— Judith Strymish (@JudithStrymish) March 22, 2019
📄 New minireview on a topic that is not simple.
— Bug Pharmacist (@IDstewardship) March 28, 2019
👉 https://t.co/bSxSgdnfc8#colistin #polymyxin via @ASMicrobiology @JClinMicro
Hopefully you aren’t using these drugs too often these days. pic.twitter.com/6leUrj8bm6
Thanks @gardp_amr for opportunity for us to share views on how to steward new antibiotics into LMICs? @ISID_org @CIDRAP_ASP @CDDEP @ESGAP_ABS @reactgroup @Wellcome_AMR @South_Centre https://t.co/QcVtVDM82A
— Marc Mendelson (@SouthAfricanASP) March 27, 2019
Correspondence @TheLancet: Methods to overcome vaccine hesitancy https://t.co/CCYhiQV6GJ
— The Lancet Infectious Diseases (@TheLancetInfDis) March 22, 2019
In June 2018, research in England has shown cancer causing HPV infections fell 86% among women aged 16 to 21 who were eligible for the vaccine during this time period reviewed. The Journal of Infectious Diseases, jiy249, https://t.co/fbcjlsacbl #ProtectOurFuture
— HSE National Immunisation Office (@HSEImm) March 28, 2019
New review on Helicobacter pylori Infection from @nejm | NEJM https://t.co/GqshSLZWKu
— SIDP (@SIDPharm) March 23, 2019
Clinical Practice Guideline for the Management of Asymptomatic Bacteriuria: 2019 Update by the Infectious
— Dr Ilin Gilberto dlT (@IlindelatorreMD) March 22, 2019
Diseases Society of Americahttps://t.co/WWkpq1jBcT pic.twitter.com/OvmZmT2y0L
New sepsis study led by @kennethbaillie is to focus on genes in quest for treatments | The University of Edinburgh @edinunimedia @roslininstitute @EdinburghUni https://t.co/Zc3OWNhR2Z
— Ed_Infect_Diseases (@edin_EID) March 27, 2019
Deeply worrying study findings - More than a quarter of people surveyed in Ebola-hit areas of the Democratic Republic of Congo told researchers they do not believe the disease exists @ISID_org @ProMED_mail https://t.co/ttw5MIRLra
— Marc Mendelson (@SouthAfricanASP) March 28, 2019
Don't miss out! #HMS physician @ValerieVaughnMD will be speaking during the April 2019 #DASON Antimicrobial #Stewardship Education Webinar Series:
— Michigan HMS (@HMS_MI) March 28, 2019
Stewardship at Transitions of Care on 4/4 & 4/11. Register here -https://t.co/a8d3ngPHz1 #pneumonia #patientsafety #antibiotics pic.twitter.com/zxNHc2rcgJ
Key considerations for decision making in #publichealth. Applies well to #Antimicrobialstewardship
— Brad Langford (@BRxAD) March 27, 2019
Initiatives. #TOPHC2019 @TOPHCtweets https://t.co/MRP3k1ax25 pic.twitter.com/ybD3o4KlzO
The drugs don’t work: what happens after antibiotics?#AntibioticResistance is progressing so quickly that the UN has called it a “global health emergency”.https://t.co/92LBQs1VHo
— Microbes&Infection (@MicrobesInfect) March 24, 2019
Perceived differences between intensivists and infectious diseases consultants facing antimicrobial resistance: a global cross-sectional survey. https://t.co/0ZTfJTbB6a
— Jordi Rello, MD, PhD (@drjordirello) March 25, 2019
Catch this live webinar with expert speaker, @TheIDApprentice
— Xtalks Webinars (@Xtalks) March 23, 2019
This webinar will address the use of #molecular rapid diagnostic tests for #bloodculture identification & the role of antimicrobial stewardship.https://t.co/V5V4mRbG2o pic.twitter.com/50dcfBIOtv
.@IDSAInfo has issued updated clinical practice guidelines for the management of ASB. “Given the current concerns about overuse of certain antimicrobial agents, this is an important antimicrobial stewardship issue,” Dr. Lindsay Nicolle said. https://t.co/TdL7PSb0ku
— ID News (@InfectDisNews) March 22, 2019
With a longstanding commitment to the fight against infectious diseases, bioMérieux is a proud advocate of tackling #AMR and promoting #AntimicrobialStewardship. Learn more on: https://t.co/wItCBNkbSN #pioneeringdiagnostics
— bioMérieux (@biomerieux) March 28, 2019
Antifungal Stewardship is a recent area of focus for @SAPGAbx - 🏴 good practice recommendations for management of #candidaemia recently agreed @jacquisneddons https://t.co/dP23K3tgLJ
— andrew seaton (@raseaton66) March 26, 2019
NEW #openaccess @jhieditor article: antibiotic use is a fairly sensitive & specific tool for identifying clusters of MDROs https://t.co/IDA0thVQ23 May also detect inter-species AMR missed by conventional surveillance methods https://t.co/nL0k5NfiWl @SidMookerjee @MGilchrist123
— Jon Otter (@jonotter) March 27, 2019
Reconfiguring a One-Way Street....important paper in Academic Medicine. Always bothered me that we send trainees overseas for rotations and they have hands on experiences yet when their trainees come over is only for observerships. A major inequality! https://t.co/qFq6FIphch
— Carlos del Rio (@CarlosdelRio7) March 28, 2019
Created by Cameron Forbes. Last updated April 19, 2019 at 07:34 EST.